Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2193-6536
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy ; day:22 ; month:3 ; year:2019 ; pages:1-10
Neurology and Therapy ; (22.3.2019), 1-10

Creator
Belmokhtar, Chafké
Lozeron, Pierre
Adams, David
Franques, Jérôme
Lacour, Arnaud
Godet, Etienne
Bataille, Mathieu
Dubourg, Odile
Angibaud, Gilles
Delmont, Emilien
Bouhour, Françoise
Corcia, Philippe
Pouget, Jean
Contributor
SpringerLink (Online service)

DOI
10.1007/s40120-019-0132-5
URN
urn:nbn:de:101:1-2019050223205715147716
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Belmokhtar, Chafké
  • Lozeron, Pierre
  • Adams, David
  • Franques, Jérôme
  • Lacour, Arnaud
  • Godet, Etienne
  • Bataille, Mathieu
  • Dubourg, Odile
  • Angibaud, Gilles
  • Delmont, Emilien
  • Bouhour, Françoise
  • Corcia, Philippe
  • Pouget, Jean
  • SpringerLink (Online service)

Other Objects (12)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast

How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

Reversible conduction failure in acute inflammatory demyelinating polyneuropathy

Reversible conduction failure in acute inflammatory demyelinating polyneuropathy

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV

Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy

Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy

Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy

Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy

Tubercular Meningitis with Acute Inflammatory Demyelinating Polyneuropathy—Trigger or Chance

Tubercular Meningitis with Acute Inflammatory Demyelinating Polyneuropathy—Trigger or Chance

Theory of mind and executive dysfunction in chronic inflammatory demyelinating polyneuropathy

Theory of mind and executive dysfunction in chronic inflammatory demyelinating polyneuropathy

Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP)

Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP)

COVID-19 infection as trigger of chronic inflammatory demyelinating polyneuropathy (CIDP)

COVID-19 infection as trigger of chronic inflammatory demyelinating polyneuropathy (CIDP)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy

Related objects